Meet the Team
Our team has unique expertise in the field of nanotechnology and its application to biomedical reasearch. This includes indeapth knowledge of nanoparticle synthesis and detailed understanding how their physicochemical parameters (size, shape, and surface chemistry) affect biological interactions, adaptation of nanotechnology for detection of infectious pathogens and development of novel nanocarriers for drug delivery.
Warren Chan, PhD
CEO & Co-Founder
Dr. Chan is one of the leaders in the field of nanotechnology with strong expertise in commericialization of scientific research. Dr. Chan holds a professorship in the Univeristy of Toronto, where he studies nanoparticle interactions with biological environment and uses unique properties of nanoparticles to develop novel diagnostic approaches and nanocarrier drug delivery solution.
Kyryl Zagorovsky, PhD
COO, CTO & Co-Founder
With over 12 years of experience in the field of nanotechnology Kyryl has gained extensive technical expertise in nanoparticle synthesis and characterization. Kyryl's work has involved development of nanotechnology-based diagnostic platforms for detection of infectious pathogens and design of multi-component nanocarrier drug delivery solutions. Kyryl oversees everyday operations and R&D activities in Luna Nanotech.
800-474-4055 ext 101
Mohamed Mohamed, PhD
Mohamed expertise combines 8 years of experience in nanotechnology with strong background of working with molecular pathogens. During his postgraduate studies and his time with Luna Nanotech Mohamed developed a range of nanomaterial formulations and successfully adapted these to a number of nanoparticle-based diagnostic assays. Mohamed is currently leading Luna Nanotech's diagnostic assay R&D projects.
800-474-4055 ext 103